Opthalmic Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

May 2020| FMR833A| Fact Market Research

Report Highlights

Global Ophthalmic Drugs Market- Scope of the Report

The recent study by Fact.MR on global ophthalmic drugs market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global ophthalmic drugs market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of ophthalmic drugs. The study also provides dynamics that are responsible for influencing the future status of the global ophthalmic drugs market over the forecast period.

A detailed assessment of the global ophthalmic drugs market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global ophthalmic drugs market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Ophthalmic Drugs Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global ophthalmic drugs market across the globe.

A comprehensive estimate of the global ophthalmic drugs market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global ophthalmic drugs during the forecast period. Price point comparison by region with global average price is also considered in the study.

This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.

Global Ophthalmic Drugs Market: Analysis on Market Size Evaluation

The global ophthalmic drugs market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for ophthalmic drugs is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent ophthalmic drugs market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Ophthalmic Drugs Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global ophthalmic drugs report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global ophthalmic drugs market during the forecast period.

Country-specific valuation on demand for ophthalmic drugs has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

Global Ophthalmic Drugs Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global ophthalmic drugs along with their detailed profiles. Essential and up-to-date data and information related to the market performers, who are principally engaged in the production of ophthalmic drugs, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global ophthalmic drugs market. Prominent manufacturers with established market presence in the global ophthalmic drugs market are Allergen, Bausch & Lomb Incorporated (Valeant Pharmaceuticals International, Inc.), Genentech, Inc., (F. Hoffmann- La Roche Ltd.), Novartis AG, Santen Pharmaceutical Co., Ltd., Aerie Pharmaceuticals, Inc., Bayer AG, Pfizer, Inc., to name a few.

  • Table 1 : Product Offering - Major Market Players
  • Table 2 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 3 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, Ophthalmic Drugs Market Forecast, by Disease Indication-Retinal Disorder, 2020-2025
  • Table 4 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 5 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2020-2025
  • Table 6 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2020-2025
  • Table 7 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2020-2025
  • Table 8 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 9 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 10 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Region, 2020-2025
  • Table 11 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Country, 2020-2025
  • Table 12 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 13 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, Ophthalmic Drugs Market Forecast, by Disease Indication-Retinal Disorder, 2020-2025
  • Table 14 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 15 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2020-2025
  • Table 16 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2020-2025
  • Table 17 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2020-2025
  • Table 18 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 19 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channels, 2020-2025
  • Table 20 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2020-2025
  • Table 21 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 22 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, Ophthalmic Drugs Market Forecast, by Disease Indication-Retinal Disorder, 2020-2025
  • Table 23 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 24 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drug, 2020-2025
  • Table 25 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drug, 2020-2025
  • Table 26 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drug, 2020-2025
  • Table 27 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 28 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 29 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2025
  • Table 30 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 31 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication-Retinal Disorder, 2020-2025
  • Table 32 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 33 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-inflammatory Drugs, 2020-2025
  • Table 34 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-infective Drugs, 2020-2025
  • Table 35 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-glaucoma Drugs, 2020-2025
  • Table 36 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 37 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 38 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2025
  • Table 39 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 40 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication-Retinal Disorder, 2020-2025
  • Table 41 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 42 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-inflammatory Drugs, 2020-2025
  • Table 43 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-infective Drugs, 2020-2025
  • Table 44 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class-Anti-glaucoma Drugs, 2020-2025
  • Table 45 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 46 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 47 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Country/Sub-Region, 2020-2025
  • Table 48 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 49 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Disease Indication - Retinal Disorder, 2020-2025
  • Table 50 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class, 2020-2025
  • Table 51 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-inflammatory Drugs, 2020-2025
  • Table 52 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-infective Drugs, 2020-2025
  • Table 53 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Therapeutic Class - Anti-glaucoma Drugs, 2020-2025
  • Table 54 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Product Type, 2020-2025
  • Table 55 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Figure 1 : Global Ophthalmic Drugs Market Size (US$ Mn) Forecast, 2020-2025
  • Figure 2 : Global Company Share
  • Figure 3 : Global Causes of Blindness
  • Figure 4 : U.S. - Causes of Blindness
  • Figure 5 : Europe - Causes of Blindness
  • Figure 6 : Japan Causes of Blindness
  • Figure 7 : Global Ophthalmic Drugs Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 8 : Global Ophthalmic Drugs Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 9 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Dry Eye, 2020-2025
  • Figure 10 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Glaucoma, 2020-2025
  • Figure 11 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Infection/Inflammation, 2020-2025
  • Figure 12 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Retinal Disorders, 2020-2025
  • Figure 13 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Uveitis, 2020-2025
  • Figure 14 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Allergy, 2020-2025
  • Figure 15 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Other Ophthalmic Diseases, 2020-2025
  • Figure 16 : Global Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 17 : Global Ophthalmic Drugs Market Value Share, by Therapeutic Class, 2020 and 2025
  • Figure 18 : Global Ophthalmic Drugs Market, by Anti-infective Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 19 : Global Ophthalmic Drugs Market, by Anti-inflammatory Drugs Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 20 : Global Ophthalmic Drugs Market, by Anti-glaucoma Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 21 : Global Ophthalmic Drugs Market, by Anti-VEGF Agents, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 22 : Global Ophthalmic Drugs Market, by Anti-allergy Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 23 : Global Ophthalmic Drugs Market, by Others Drugs, Revenue (US$ Mn) and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 24 : Global Ophthalmic Drugs Market Value Share, by Product Type, for 2020 and 2025
  • Figure 25 : Global Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 26 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Prescription Drugs, 2020-2025
  • Figure 27 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by OTC Drugs, 2020-2025
  • Figure 28 : Global Ophthalmic Drugs Market Value Share, by Distribution Channel, for 2020 and 2025
  • Figure 29 : Global Ophthalmic Drugs Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 30 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Online Pharmacies, 2020-2025
  • Figure 31 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Hospital Pharmacies, 2020-2025
  • Figure 32 : Global Ophthalmic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Independent Pharmacies & Drug Stores, 2020-2025
  • Figure 33 : Global Ophthalmic Drugs Market Value Share, by Region, for 2020 and 2025
  • Figure 34 : Global Ophthalmic Drugs Market Attractiveness, by Region, 2020-2025
  • Figure 35 : North America Ophthalmic Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 36 : North America Ophthalmic Drugs Market Attractiveness, by Country, 2020-2025
  • Figure 37 : North America Ophthalmic Drugs Market Value Share, by Country, 2020 and 2025
  • Figure 38 : North America Ophthalmic Drugs Market Attractiveness, By Disease Indication, 2020-2025
  • Figure 39 : North America Ophthalmic Drugs Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 40 : North America Ophthalmic Drugs Market Value Share, by Therapeutic Class, 2020 and 2025
  • Figure 41 : North America Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 42 : North America Ophthalmic Drugs Market Value Share Analysis, by Product Type, 2020 and 2025
  • Figure 43 : North America Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 44 : North America Ophthalmic Drugs Market Value Share, by Distribution Channels, 2020 and 2025
  • Figure 45 : North America Ophthalmic Drugs Market Attractiveness, by Distribution Channels, 2020-2025
  • Figure 46 : Europe Ophthalmic Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 47 : Europe Ophthalmic Drugs Market Attractiveness, by Country/Sub-Region, 2020-2025
  • Figure 48 : Europe Ophthalmic Drugs Market Value Share, by Country/Sub-Region, 2020 and 2025
  • Figure 49 : Europe Ophthalmic Drugs Market Attractiveness, By Disease Indication, 2015-2025
  • Figure 50 : Europe Ophthalmic Drugs Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 51 : Europe Ophthalmic Drugs Market Value Share, by Therapeutic Class, 2020 and 2025
  • Figure 52 : Europe Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 53 : Europe Ophthalmic Drugs Market Value Share Analysis, by Product Type, 2020 and 2025
  • Figure 54 : Europe Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 55 : Europe Ophthalmic Drugs Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 56 : Europe Ophthalmic Drugs Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 57 : Asia Pacific Ophthalmic Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2025
  • Figure 58 : Asia Pacific Ophthalmic Drugs Market Attractiveness, by Country/Sub-region, 2020-2025
  • Figure 59 : Asia Pacific Ophthalmic Drugs Market Value Share, by Country/Sub-region, for 2020 and 2025
  • Figure 60 : Asia Pacific Ophthalmic Drugs Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 61 : Asia Pacific Ophthalmic Drugs Market Value Share, by Disease Indication, for 2020 and 2025
  • Figure 62 : Asia Pacific Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 63 : Asia Pacific Ophthalmic Drugs Market Value Share, by Therapeutic Class, for 2020 and 2025
  • Figure 64 : Asia Pacific Ophthalmic Drugs Market Value Share Analysis, by Product Type, for 2020 and 2025
  • Figure 65 : Asia Pacific Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 66 : Asia Pacific Ophthalmic Drugs Market Value Share, by Distribution Channel, for 2020 and 2025
  • Figure 67 : Asia Pacific Ophthalmic Drugs Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 68 : Latin America Ophthalmic Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 69 : Latin America Ophthalmic Drugs Market Attractiveness, by Country/Sub-region, 2020-2025
  • Figure 70 : Latin America Ophthalmic Drugs Market Value Share, by Country/Sub-region, 2020 and 2025
  • Figure 71 : Latin America Ophthalmic Drugs Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 72 : Latin America Ophthalmic Drugs Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 73 : Latin America Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 74 : Latin America Ophthalmic Drugs Market Value Share, by Therapeutic Class, 2020 and 2025
  • Figure 75 : Latin America Ophthalmic Drugs Market Value Share Analysis, by Product Type, 2020 and 2025
  • Figure 76 : Latin America Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 77 : Latin America Ophthalmic Drugs Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 78 : Latin America Ophthalmic Drugs Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 79 : Middle East & Africa Ophthalmic Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2020-2025
  • Figure 80 : Middle East & Africa Ophthalmic Drugs Market Attractiveness, by Country/Sub-Region, 2020-2025
  • Figure 81 : Middle East & Africa Ophthalmic Drugs Market Value Share, by Country/Sub-Region, 2020 and 2025
  • Figure 82 : Middle East & Africa Ophthalmic Drugs Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 83 : Middle East & Africa Ophthalmic Drugs Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 84 : Middle East & Africa Ophthalmic Drugs Market Attractiveness, by Therapeutic Class, 2020-2025
  • Figure 85 : Middle East & Africa Ophthalmic Drugs Market Value Share, by Therapeutic Class, 2020 and 2025
  • Figure 86 : Middle East & Africa Ophthalmic Drugs Market Value Share Analysis, by Product Type, 2020 and 2025
  • Figure 87 : Middle East & Africa Ophthalmic Drugs Market Attractiveness, by Product Type, 2020-2025
  • Figure 88 : Middle East & Africa Ophthalmic Drugs Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 89 : Middle East & Africa Ophthalmic Drugs Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 90 : Global Ophthalmic Drugs Market Share, by Company, 2018

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report